Skip to content

China Asthma Data Registry and Online Management Platform Construction Project

China Asthma Data Registry and Online Management Platform Construction Project

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111740
Enrollment
Unknown
Registered
2025-11-05
Start date
2020-08-13
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age over 5 years, weight >=15 kg; 2. Presents clinical symptoms and/or signs of asthma: (1) Recurrent attacks of wheezing and shortness of breath, with or without chest tightness or cough, occurring mainly at night and in the morning, often related to exposure to allergens, cold air, physical or chemical stimuli, upper respiratory tract infections, exercise, etc.; (2) During attacks, scattered or diffuse wheezing can be heard in both lungs, with prolonged expiratory phase; (3) The above symptoms and signs can be relieved with treatment or resolve spontaneously; 3. Within the past 12 months, at least one of the following objective tests indicating variable airflow limitation: (1) Positive bronchodilator test (after inhalation of a bronchodilator, FEV1 increases by >12% and the absolute value of FEV1 increases by >200 ml); (2) Positive bronchial provocation test; (3) Peak expiratory flow (PEF) with an average daily diurnal variability rate (over 7 consecutive days, sum of daily PEF diurnal variability/7) >10%, or weekly PEF variability rate [(highest PEF value within 2 weeks - lowest PEF value within 2 weeks)/((highest PEF + lowest PEF)/2) × 100%] >20%.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Clinical characteristics;Demographics;Laboratory investigations;Disease assessment;Treatment mode;

Secondary

MeasureTime frame
Airway inflammation;Prognosis;Symptoms distribution;

Countries

China

Contacts

Public ContactLai Kefang

The First Affiliated Hospital of Guangzhou Medical University

klai@vip.163.com+86 20 8156 6841

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026